Company Filing History:
2 out of 1,164 
1 out of 23 Years Active: 1997-2001
Title: The Innovations of Harald Funke
Introduction
Harald Funke is a notable inventor based in Munster, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of apolipoproteins and nucleic acid detection. With a total of 3 patents to his name, Funke's work has implications for both therapeutic applications and genetic research.
Latest Patents
One of Funke's latest patents is focused on variants of apolipoprotein A-I. This invention relates to variants of the human apolipoprotein A-I that include a cysteine at position 151. It encompasses the corresponding nucleic acids and vectors containing them. Additionally, it discusses pharmaceutical compositions that include these elements and their use in gene therapy. Another significant patent involves a method for detecting variant nucleic acids using extension. This method identifies nucleic acids with differing nucleotide sequences at a specific position, utilizing a set of oligonucleotides that are complementary to the variant nucleic acids at that position.
Career Highlights
Throughout his career, Harald Funke has worked with prominent companies in the pharmaceutical industry. He has been associated with Boehringer Mannheim GmbH and Aventis Pharmaceuticals Products Inc. His work in these organizations has allowed him to contribute to various innovative projects and advancements in biotechnology.
Collaborations
Funke has collaborated with notable colleagues in his field, including Gerd Assmann and Stephan Rust. These collaborations have likely enriched his research and contributed to the success of his inventions.
Conclusion
Harald Funke's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the fields of gene therapy and nucleic acid detection.